111 related articles for article (PubMed ID: 8964088)
21. Peptides of 23 residues or greater are required to stimulate a high affinity class II-restricted T cell response.
Srinivasan M; Domanico SZ; Kaumaya PT; Pierce SK
Eur J Immunol; 1993 May; 23(5):1011-6. PubMed ID: 8386663
[TBL] [Abstract][Full Text] [Related]
22. Immunodominance does not result from peptide competition for MHC class II presentation.
Lo-Man R; Langeveld JP; Martineau P; Hofnung M; Meloen RH; Leclerc C
J Immunol; 1998 Feb; 160(4):1759-66. PubMed ID: 9469434
[TBL] [Abstract][Full Text] [Related]
23. Broad recognition of cytotoxic T cell epitopes from the HIV-1 envelope protein with multiple class I histocompatibility molecules.
Shirai M; Pendleton CD; Berzofsky JA
J Immunol; 1992 Mar; 148(6):1657-67. PubMed ID: 1371784
[TBL] [Abstract][Full Text] [Related]
24. T cell immunity to type II collagen in the biobreeding rat: the identification and characterization of RT1u-restricted T cell epitopes on alpha 1(II).
Cremer MA; Ye XJ; Myers LK; Brand DD; Rosloniec EF; Kang AH
J Immunol; 2004 Aug; 173(3):1795-801. PubMed ID: 15265910
[TBL] [Abstract][Full Text] [Related]
25. Relative contribution of "determinant selection" and "holes in the T-cell repertoire" to T-cell responses.
Schaeffer EB; Sette A; Johnson DL; Bekoff MC; Smith JA; Grey HM; Buus S
Proc Natl Acad Sci U S A; 1989 Jun; 86(12):4649-53. PubMed ID: 2471972
[TBL] [Abstract][Full Text] [Related]
26. Dominant and cryptic antigens in the MHC class I restricted T cell response across a complex minor histocompatibility barrier: analysis and mapping by elution of cellular peptides.
Wolpert E; Franksson L; Kärre K
Int Immunol; 1995 Jun; 7(6):919-28. PubMed ID: 7577800
[TBL] [Abstract][Full Text] [Related]
27. Distinction between immunogenicity and tolerogenicity among HBcAg T cell determinants. Influence of peptide-MHC interaction.
Milich DR; Jones JE; McLachlan A; Houghten R; Thornton GB; Hughes JL
J Immunol; 1989 Nov; 143(10):3148-56. PubMed ID: 2478619
[TBL] [Abstract][Full Text] [Related]
28. Truncation variants of peptides isolated from MHC class II molecules suggest sequence motifs.
Rudensky AYu ; Preston-Hurlburt P; al-Ramadi BK; Rothbard J; Janeway CA
Nature; 1992 Oct; 359(6394):429-31. PubMed ID: 1328884
[TBL] [Abstract][Full Text] [Related]
29. Allogeneic core amino acids of an immunodominant allopeptide are important for MHC binding and TCR recognition.
Sitaru AG; Timmermann W; Ulrichs K; Otto C
Hum Immunol; 2004 Aug; 65(8):817-25. PubMed ID: 15336783
[TBL] [Abstract][Full Text] [Related]
30. T cells that recognize peptide sequences of self MHC class II molecules exist in syngeneic mice.
Agrawal B; Manickasundari M; Fraga E; Singh B
J Immunol; 1991 Jul; 147(2):383-90. PubMed ID: 1649218
[TBL] [Abstract][Full Text] [Related]
31. Silencing of immunodominant epitopes by contiguous sequences in complex synthetic peptides.
Wang Y; Smith JA; Kamradt T; Gefter ML; Perkins DL
Cell Immunol; 1992 Sep; 143(2):284-97. PubMed ID: 1380894
[TBL] [Abstract][Full Text] [Related]
32. Minute quantities of a single immunodominant foreign epitope are presented as large nested sets by major histocompatibility complex class II molecules.
Vignali DA; Urban RG; Chicz RM; Strominger JL
Eur J Immunol; 1993 Jul; 23(7):1602-7. PubMed ID: 7686856
[TBL] [Abstract][Full Text] [Related]
33. Antigen presentation to specific T cells by Ia molecules selectively altered by site-directed mutagenesis.
Brett SJ; McKean D; York-Jolley J; Berzofsky JA
Int Immunol; 1989; 1(2):130-40. PubMed ID: 2518656
[TBL] [Abstract][Full Text] [Related]
34. Diversity of the class II (I-Ak/I-Ek)-restricted T cell repertoire for influenza hemagglutinin and antigenic drift. Six nonoverlapping epitopes on the HA1 subunit are defined by synthetic peptides.
Burt DS; Mills KH; Skehel JJ; Thomas DB
J Exp Med; 1989 Aug; 170(2):383-97. PubMed ID: 2474053
[TBL] [Abstract][Full Text] [Related]
35. The structural basis of MHC control of collagen-induced arthritis; binding of the immunodominant type II collagen 256-270 glycopeptide to H-2Aq and H-2Ap molecules.
Kjellén P; Brunsberg U; Broddefalk J; Hansen B; Vestberg M; Ivarsson I; Engström A; Svejgaard A; Kihlberg J; Fugger L; Holmdahl R
Eur J Immunol; 1998 Feb; 28(2):755-67. PubMed ID: 9521085
[TBL] [Abstract][Full Text] [Related]
36. Fine specificity of murine class II-restricted T cell clones for synthetic peptides of influenza virus hemagglutinin. Heterogeneity of antigen interaction with the T cell and the Ia molecule.
Mills KH; Burt DS; Skehel JJ; Thomas DB
J Immunol; 1988 Jun; 140(12):4083-90. PubMed ID: 2453566
[TBL] [Abstract][Full Text] [Related]
37. Immunodominance: intermolecular competition between MHC class II molecules by covalently linked T cell epitopes.
Wang Y; Smith JA; Gefter ML; Perkins DL
J Immunol; 1992 May; 148(10):3034-41. PubMed ID: 1578129
[TBL] [Abstract][Full Text] [Related]
38. Invariant chain peptides enhancing or inhibiting the presentation of antigenic peptides by major histocompatibility complex class II molecules.
Adams S; Humphreys RE
Eur J Immunol; 1995 Jun; 25(6):1693-702. PubMed ID: 7614997
[TBL] [Abstract][Full Text] [Related]
39. Constitutive presentation of dominant epitopes from endogenous naturally processed self-beta 2-microglobulin to class II-restricted T cells leads to self-tolerance.
Guéry JC; Sette A; Appella E; Adorini L
J Immunol; 1995 Jan; 154(2):545-54. PubMed ID: 7814867
[TBL] [Abstract][Full Text] [Related]
40. Immunodominant mink cell focus-inducing murine leukemia virus (MuLV)-encoded CTL epitope, identified by its MHC class I-binding motif, explains MuLV-type specificity of MCF-directed cytotoxic T lymphocytes.
Sijts AJ; Ossendorp F; Mengedé EA; van den Elsen PJ; Melief CJ
J Immunol; 1994 Jan; 152(1):106-16. PubMed ID: 8254184
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
